Table 4.
Summary of the AJCC 6th edition, AJCC 7th edition, UICC, and BWH tumor- (T-) stage systems.
T-stage | AJCC 6th | AJCC 7th | UICC | T-stage | BWH |
---|---|---|---|---|---|
T1 | Tumor 2 cm or less in greatest dimension | Tumor <2 cm in greatest dimension with fewer than two “high-risk” features∗ | Tumor ≤2 cm in largest horizontal size | T1 | 0 high-risk factors‡ |
| |||||
T2 | Tumor more than 2 cm but not more than 5 cm in greatest dimension | Tumor >2 cm in greatest dimension or tumor any size with two or more “high-risk” features∗ | Tumor >2 cm in largest horizontal size | T2a | 1 high-risk factor‡ |
T2b | 2-3 high risk factors‡ | ||||
| |||||
T3 | Tumor more than 5 cm in greatest dimension | Tumor with invasion of orbit, maxilla, mandible, or temporal bones | Deep infiltration (skeleton muscle, cartilage, or bone) | T3 | ≥4 high risk factors‡ |
| |||||
T4 | Tumor invades deep extradermal structures (i.e., cartilage, skeleton muscle, or bone) | Tumor with invasion of skeleton (axial or appendicular) or perineural invasion of skull base | Infiltration of base of skull or vertebra | T4 | n/a |
*AJCC high-risk factors include >2 mm thickness, Clark level ≥IV, perineural invasion, primary site ear, primary site non-hair-bearing lip, or poorly differentiated histology.
‡BWH “high-risk” factors include tumor diameter ≥2 cm, poorly differentiated histology, perineural invasion ≥0.1 mm, or tumor invasion beyond fat (excluding bone invasion which automatically upgrades tumor to BWH stage T3).